Table 1.
Studies reporting on the effects of Covid-19 on γδ T cells and related cytokines.
| Donor Cohort | Covid-19 Patients | Blood vs Tissue | Ref | |
|---|---|---|---|---|
| γδ T cells | 98 healthy controls, 7 healthy child controls, 25 child patients, 68 patients | Decreased | Not significant | (55, 68–70) |
| δ2 T cells | 92 healthy controls, 84 adult patients | Decreased | NA | (55, 67, 70) |
| δ1 T cells | 20 healthy controls, 30 adult patients | No significant difference | NA | (55) |
| Activation Markers | 38 healthy controls, 68 patients | Increased | NA | (55, 68) |
| Exhaustion Markers | 20 healthy controls, 30 patients | increased | Higher in Tissue than in Blood | (55) |
| IFN-γ | 20 healthy controls, 7 healthy child controls, 30 patients, 23 child patients | No significant difference | Higher in Tissue than in Blood | (55, 69) |
NA, not applicable.